EphB2 expression was found to be stepwise increased from normal liver tissues to cirrhotic liver tissues and to hepatocellular carcinoma (HCC) tissues and associated with poor prognosis (Mimche et al., 2015b; Butler and Schmidt, 2015; Leung et al., 2021). Here, EPHB2 is linked to hepatocellular carcinoma.